Retrospective Comparison of Efficacy and Safety of Basiliximab and Antithymocyte Globulin in Kidney Transplant Recipients. (2021). Khartoum Journal of Pharmaceutical Sciences, 1(1). https://doi.org/10.53332/kjps.v1i1.40